Related references
Note: Only part of the references are listed.Impact of Neoadjuvant Chemotherapy on Locoregional Surgical Treatment of Breast Cancer
Eleftherios P. Mamounas
ANNALS OF SURGICAL ONCOLOGY (2015)
Role of Imaging in Neoadjuvant Therapy for Breast Cancer
Vandana Dialani et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Neoadjuvant Chemotherapy for Breast Cancer Increases the Rate of Breast Conservation: Results from the National Cancer Database
Brigid K. Killelea et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
St. Gallen Consensus 2013: Optimizing and Personalizing Primary Curative Therapy of Breast Cancer Worldwide
Hans-Joerg Senn
BREAST CARE (2013)
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer Translational Breast Cancer Research Consortium Trial 017
Jennifer F. De los Santos et al.
CANCER (2013)
Time to stop operating on breast cancer patients with pathological complete response?
D. Rea et al.
EJSO (2013)
Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
Michael L. Marinovich et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines
A. Lebeau et al.
PATHOLOGE (2013)
Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?
J. Heil et al.
ANNALS OF ONCOLOGY (2012)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
MRI Staging After Neoadjuvant Chemotherapy for Breast Cancer: Does Tumor Biology Affect Accuracy?
Kandace P. McGuire et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Francesco Sardanelli et al.
EUROPEAN JOURNAL OF CANCER (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
First revision of the German S3 guideline 'diagnosis, therapy, and follow-up of breast cancer'
Achim Woeckel et al.
BREAST CARE (2008)
Intensified neoadjuvant chemotherapy in early-responding breast cancer:: Phase III randomized GeparTrio study
Gunter von Minckwitz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete Pathologic response after Neoadjuvant chemotherapy
Neal S. Goldstein et al.
CANCER (2007)
HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination
Daniel G. Tiezzi et al.
BMC CANCER (2007)
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Reader variability in reporting breast imaging according to BI-RADS® assessment categories (the Florence experience)
S Ciatto et al.
BREAST (2006)
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy
AB Chagpar et al.
ANNALS OF SURGERY (2006)
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
L Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration
PM Bossuyt et al.
CLINICAL CHEMISTRY (2003)
Share Paper
